The ninth president: Lin Gui, 1988.8-1991.11
1938¡«1992. Lin Gui was a famous radiology specialist, one of the founders of interventional radiology of China, member of Chinese Communist Party, member of the academic board of former Shanghai Medical College, associate director of Medical Imaging Center and member of the Party Committee of Zhongshan Hospital. He succesively served as the vice president, president of Zhongshan Hospital, the director of Radiology Department, member of the Radiological Society of Chinese Medical Association, member of the Gastric Cancer Specialized Committee of Chinese Anti-Cancer Association, member of Shanghai Radiological Society, the deputy editor of Chinese Journal of Radiology, counselor of Journal of Clinical Radiology, member of Final Judging Committee for Science and Technology Achievement Award of Ministry of Health, member of Radiological Society of North America (RSNA), member of Cardiovascular And Interventional Radiological Society Of Europe (CIRSE), and member of International Continuing Education Committee of Radiology.
In 1957, Lin Gui was admitted to Shanghai First Medical College with excellent academic performance. He had a firm political stand, worked hard, made earnest efforts to promote public good, and joined the Communist Party in 1959 with honors. In 1962, he graduated and was assigned to work in Zhongshan Hospital, studying under Prof. Rong Dushan, one the founders of radiology in China. With the nurturing of his college and the hospital, he was promoted to associate director of Radiology Department. Dr. Lin was diligent and eager to learn, and accumulated experience with over ten thousand cases of gastrointestinal X - ray examinations. He published 29 papers, including “X-ray Diagnosis of Early Gastric Cancer” and “the Differentiation of Ileocecal Malignant Tumor and Inflammation”. During the Cultural Revolution, he worked on a washboard for five years with three generations living in a small room until he finished assisting Prof. Rong Dushan with compiling X-ray Diagnosis. He was highly praised by Prof. Rong.
In 1981, sponsored by the State Education Commission, Prof. Lin Gui went to Lund University in Sweden to pursue further studies. He focused on angiography and interventional therapy and in only two years he completed 5 research projects and published 11 papers. In 1983, at the International Angiography Seminar held in Yugoslavia, Dr. Lin pointed out that hepatoma had double blood supply, which further laid the foundation for embolotherapy in hepatoma treatment, and was favorable received by experts from other countries. He returned to China on schedule after receiving his doctoral degree in medical science.
Dr. Lin published 129 papers in journals both at home and abroad. He wrote Interventional Radiology and Selective Angiography, and participated in the compiling of 18 monographs, including X-ray Diagnosis and X-ray anatomy. He put great emphasis on fundamental research and completed 6 key scientific research projects at national and municipal level, among which “the Experimental Research and Clinical Application of Hepatic and Renal Tumor Embolism” won the second prize of Scientific and Technological Achievement Award of Ministry of Health, and three other projects won the prize of Scientific and Technological Achievement Award of Shanghai Municipality. Lin Gui was frequently invited to give reports on his research findings of interventional radiology in 12 countries including America, West Germany, France and Sweden. His academic activities helped China’s interventional radiology to reach the international acclaim. In 1988, he was honored with Young Expert with Outstanding Contributions title, and in 1989, he was nominated for Shanghai Science and Technology Elite, and his name was included in the Who’s Who and the Dictionary of Celebrity Biography in the U.S. and Britain.
Lin Gui engaged himself in diagnostic radiology, interventional radiology and hospital management for 30 years, contributing his energy and wisdom to the development of medical science in China.